|
| Clara Oromendia | |
| Kenneth Eng | Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, USA Institute for Computational Biomedicine |
| Rohan Bareja | Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, USA Institute for Computational Biomedicine |
| Michael Sigouros | |
| Ana M Molina | USA Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital |
| Bishoy M Faltas | USA Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital |
| Andrea Sboner | Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, USA Institute for Computational Biomedicine |
| Andrea Sboner | Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, USA Institute for Computational Biomedicine |
| Juan Miguel Mosquera | Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital |
| Juan Miguel Mosquera | Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital |
| Olivier Elemento | Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, USA Institute for Computational Biomedicine |
| Olivier Elemento | Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, USA Institute for Computational Biomedicine |
| David M Nanus | USA Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital |
| Scott T Tagawa | USA Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital |
| Himisha Beltran | USA Dana Farber Cancer Institute and Harvard Medical School |
| Himisha Beltran | USA Dana Farber Cancer Institute and Harvard Medical School |